Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomized Study of Cabazitaxel vs Topotecan in Relapsed Small Cell Lung Cancer
2011-003415-31Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2011
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in small cell lung cancer (SCLC) comparing Cabazitaxel arm with Topotecan arm (2 arms). Primary endpoint: Progression-free survival. Started Dec 2011; status: completed.
02
Drugs
cabazitaxeltopotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2011-003415-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003415-31.